IFN-γ- and IL-17-producing CD8(+) T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity

BACKGROUND: While adoptive transfer of T-cells has been a major medical breakthrough for patients with B cell malignancies, the development of safe and effective T-cell-based immunotherapy for central nervous system (CNS) tumors, such as glioblastoma (GBM), still needs to overcome multiple challenge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohkuri, Takayuki, Kosaka, Akemi, Ikeura, Maki, Salazar, Andres M, Okada, Hideho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246372/
https://www.ncbi.nlm.nih.gov/pubmed/34193567
http://dx.doi.org/10.1136/jitc-2021-002426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246372/
https://www.ncbi.nlm.nih.gov/pubmed/34193567
http://dx.doi.org/10.1136/jitc-2021-002426

Ejemplares similares